Jacobson Pharma Corporation Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jacobson Pharma Corporation Ltd with three other
pharmaceutical manufacturers in Asia:
sales of 15.90 billion Indian Rupees [US$222.86 million]
of which 59%
was Pharmaceutical Products),
(28.38 billion Japanese Yen [US$258.29 million]
of which 77%
was Pharmaceutical Products), and
Aarti Drugs Limited
based in India
(15.61 billion Indian Rupees [US$218.84 million]
of which 100%
During the year ended March of 2019, sales at
Jacobson Pharma Corporation Ltd were HK$1.70 billion (US$219.44 million).
increase of 10.1%
versus 2018, when the company's sales were HK$1.55 billion.
This was the fifth consecutive year of sales increases at Jacobson Pharma Corporation Ltd
(and since 2014, sales have increased a total of 84%).
Sales of Wholesale and Retail saw an increase
that was more than double the company's growth rate: sales were up
27.5% in 2019, from
HK$177.65 million to HK$226.52 million.
Jacobson Pharma Corporation Ltd also saw significant increases in sales in
Proprietary Chinese Medicines (up 17.1% to HK$225.10 million)